pI: 8.2967 |
Length (AA): 375 |
MW (Da): 41228 |
Paralog Number:
10
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 9
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_127586)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G18190 | purine permease 6 |
Brugia malayi | Bm1_42075 | zgc:92765 |
Candida albicans | CaO19.10408 | hypothetical protein |
Candida albicans | CaO19.2890 | hypothetical protein |
Caenorhabditis elegans | CELE_C29H12.2 | Protein C29H12.2 |
Drosophila melanogaster | Dmel_CG10007 | Transport and Golgi organization 9 |
Entamoeba histolytica | EHI_147870 | hypothetical protein, conserved |
Entamoeba histolytica | EHI_006940 | hypothetical protein, conserved |
Entamoeba histolytica | EHI_131130 | hypothetical protein, conserved |
Entamoeba histolytica | EHI_092680 | hypothetical protein, conserved |
Entamoeba histolytica | EHI_152470 | hypothetical protein, conserved |
Giardia lamblia | GL50803_22291 | Hypothetical protein |
Giardia lamblia | GL50803_9036 | Hypothetical protein |
Homo sapiens | ENSG00000213699 | solute carrier family 35, member F6 |
Leishmania braziliensis | LbrM.35.0790 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_360730.1 | EamA-like transporter family, putative |
Leishmania infantum | LinJ.36.0730 | hypothetical protein, conserved |
Leishmania major | LmjF.36.0670 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.36.0670 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_02297 | hypothetical protein |
Mus musculus | ENSMUSG00000029175 | solute carrier family 35, member F6 |
Onchocerca volvulus | OVOC10794 | Solute carrier family 35 member F6 homolog |
Schistosoma japonicum | Sjp_0021820 | similar to Uncharacterized protein C2orf18 precursor, putative |
Schistosoma mansoni | Smp_163220 | hypothetical protein |
Schmidtea mediterranea | mk4.015879.01 | Solute carrier family 35 member F6 |
Trichomonas vaginalis | TVAG_197230 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_263910 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_328950 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_019740 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_286280 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_254470 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_203880 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_432780 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_497440 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_005580 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_492760 | conserved hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
CELE_C29H12.2 | Caenorhabditis elegans | slow growth | wormbase |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.